NCT00410644View on ClinicalTrials.gov

A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

463

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1999

Conditions
PainAnalgesicsOpioid
Interventions
DRUG

OROS Hydromorphone HCI

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00410644 - A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain | Biotech Hunter | Biotech Hunter